Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MS.
Assay
Iohexol
Tandem mass spectrometry
Validation
Journal
Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336
Informations de publication
Date de publication:
10 Sep 2020
10 Sep 2020
Historique:
received:
30
12
2019
revised:
01
07
2020
accepted:
05
07
2020
pubmed:
14
7
2020
medline:
22
6
2021
entrez:
14
7
2020
Statut:
ppublish
Résumé
We developed a high-performance liquid chromatography mass spectrometry method for quantitating iohexol in 50 μL human plasma. After acetonitrile protein precipitation, chromatographic separation was achieved with a Shodex Asahipak NH2P-50 2D (5 μm, 2 × 150 mm) column and a gradient of 0.1 % formic acid in acetonitrile and 0.1 % formic acid in water over a 10 min run time. Mass spectrometric detection was performed on a Micromass Quatromicro triple-stage bench-top mass spectrometer with electrospray, positive-mode ionization. The assay was linear from 1 to 500 μg/mL for iohexol, proved to be accurate (101.3-102.1 %) and precise (<3.4 %CV), and fulfilled Food and Drug Administration (FDA) criteria for bioanalytical method validation. Recovery from plasma was 53.1-64.2 % and matrix effect was trivial (-3.4 to -1.3 %). Plasma freeze thaw stability (97.4-99.4 %), stability for 5 months at -80 °C (95.5-103.3 %), and stability for 4 h at room temperature (100.6-103.3 %) were all acceptable. This validated assay using a deuterated internal standard will be an important tool in measuring iohexol clearance and determining glomerular filtration rate (GFR) in patients.
Identifiants
pubmed: 32659569
pii: S0731-7085(20)31350-9
doi: 10.1016/j.jpba.2020.113464
pmc: PMC7484441
mid: NIHMS1610160
pii:
doi:
Substances chimiques
Iohexol
4419T9MX03
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113464Subventions
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211241
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA247643
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186690
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors report no declarations of interest.
Références
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):587-595
pubmed: 30890575
Clin Chim Acta. 2016 Dec 1;463:96-102
pubmed: 27756544
Am J Kidney Dis. 2013 Jan;61(1):57-66
pubmed: 22889713
Invest Radiol. 1983 Mar-Apr;18(2):177-82
pubmed: 6408018
Methods Mol Biol. 2009;466:61-72
pubmed: 19148601
Invest Radiol. 1988 Sep;23 Suppl 1:S106-9
pubmed: 3198329
J Am Soc Nephrol. 1995 Aug;6(2):257-63
pubmed: 7579093
Am J Kidney Dis. 2018 Feb;71(2):163-165
pubmed: 29217306
J Sep Sci. 2006 Aug;29(12):1784-821
pubmed: 16970185
J Lab Clin Med. 1984 Dec;104(6):955-61
pubmed: 6438261
Clin Chem. 2009 Jun;55(6):1196-202
pubmed: 19359533
J Pharm Biomed Anal. 2017 May 10;138:197-205
pubmed: 28219796